This work is licensed under the Creative Commons Attribution 4.0 International License.
Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-24. 10.1002/bjs.7669TiongLMaddernGJ.Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinomaBr J Surg20119812102410.1002/bjs.7669Open DOISearch in Google Scholar
Nouso K, Shiraga K, Uematsu S, Okamoto R, Harada R, Takayama S, et al. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma. Liver Int 2005; 25: 967-72. 10.1111/j.1478-3231.2005.01145.xNousoKShiragaKUematsuSOkamotoRHaradaRTakayamaSPrediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinomaLiver Int2005259677210.1111/j.1478-3231.2005.01145.xOpen DOISearch in Google Scholar
Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, et al. Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation. Hepatogastroenterology 2011; 58: 1638-42. 10.5754/hge08641KodaMMandaiMMatonoTSugiharaTNagaharaTUekiMAssessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigationHepatogastroenterology20115816384210.5754/hge08641Open DOISearch in Google Scholar
Minami Y, Kudo M. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence. Dig Dis 2014; 32: 690-5. 10.1159/000368001MinamiYKudoMUltrasound fusion imaging of hepatocellular carcinoma: a review of current evidenceDig Dis201432690510.1159/000368001Open DOISearch in Google Scholar
Toshikuni N, Tsutsumi M, Takuma Y, Arisawa T. Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma. J Ultrasound Med 2014; 33: 2005-10. 10.7863/ultra.33.11.2005ToshikuniNTsutsumiMTakumaYArisawaTReal-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinomaJ Ultrasound Med20143320051010.7863/ultra.33.11.2005Open DOISearch in Google Scholar
Kawasoe H, Eguchi Y, Mizuta T, Yasutake T, Ozaki I, Shimonishi T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr 2007; 40: 66-72. 10.3164/jcbn.40.66KawasoeHEguchiYMizutaTYasutakeTOzakiIShimonishiTRadiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonographyJ Clin Biochem Nutr200740667210.3164/jcbn.40.66Open DOISearch in Google Scholar
Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008; 38: 565-71. 10.1111/j.1872-034X.2007.00308.xKitadaTMurakamiTKuzushitaNMinamitaniKNakajoKOsugaKEffectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomasHepatol Res2008385657110.1111/j.1872-034X.2007.00308.xOpen DOISearch in Google Scholar
Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008; 190: W335-41. 10.2214/ajr.07.3092MinamiYChungHKudoMKitaiSTakahashiSInoueTRadiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigationAJR Am J Roentgenol2008190W3354110.2214/ajr.07.3092Open DOISearch in Google Scholar
Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, et al. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009; 32: 62-9. 10.1007/s00270-008-9462-xNakaiMSatoMSaharaSTakasakaIKawaiNMinamiguchiHRadiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonographyCardiovasc Intervent Radiol20093262910.1007/s00270-008-9462-xOpen DOISearch in Google Scholar
Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol 2012; 198: 1438-44. 10.2214/ajr.11.7568LeeMWRhimHChaDIKimYJChoiDKimYSPercutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonographyAJR Am J Roentgenol201219814384410.2214/ajr.11.7568Open DOISearch in Google Scholar
Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol 2013; 201: 1141-7. 10.2214/ajr.13.10532SongKDLeeMWRhimHChaDIChongYLimHKFusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasoundAJR Am J Roentgenol20132011141710.2214/ajr.13.10532Open DOISearch in Google Scholar
Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, et al. Real-time US-CT/MR Fusion Imaging for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma. J Hepatol 2016. 10.1016/j.jhep.2016.09.003AhnSJLeeJMLeeDHLeeSMYoonJHKimYJReal-time US-CT/MR Fusion Imaging for Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaJ Hepatol201610.1016/j.jhep.2016.09.003Open DOISearch in Google Scholar
Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. 10.1002/hep.20933BruixJShermanMPractice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinomaHepatology20054212083610.1002/hep.20933Open DOISearch in Google Scholar
Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51(Suppl 1): 61-9. 10.1159/000122600HatanakaKKudoMMinamiYUedaTTatsumiCKitaiSDifferential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, SonazoidIntervirology200851(Suppl 1)61910.1159/000122600Open DOISearch in Google Scholar
Toshikuni N, Shiroeda H, Ozaki K, Matsue Y, Minato T, Nomura T, et al. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. Radiol Oncol 2013; 47: 224-9. 10.2478/raon-2013-0033ToshikuniNShiroedaHOzakiKMatsueYMinatoTNomuraTAdvanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinomaRadiol Oncol201347224910.2478/raon-2013-0033Open DOISearch in Google Scholar
Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-64. 10.1159/000327577KudoMIzumiNKokudoNMatsuiOSakamotoMNakashimaOManagement of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated versionDig Dis2011293396410.1159/000327577Open DOISearch in Google Scholar
Minami T, Minami Y, Chishina H, Arizumi T, Takita M, Kitai S, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 2014; 87(Suppl 1): 55-62. 10.1159/000368146MinamiTMinamiYChishinaHArizumiTTakitaMKitaiSCombination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imagingOncology201487(Suppl 1)556210.1159/000368146Open DOISearch in Google Scholar
Uehara T, Hirooka M, Ishida K, Hiraoka A, Kumagi T, Kisaka Y, et al. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol 2007; 42: 306-11. 10.1007/s00535-006-1949-0UeharaTHirookaMIshidaKHiraokaAKumagiTKisakaYPercutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascitesJ Gastroenterol2007423061110.1007/s00535-006-1949-0Open DOISearch in Google Scholar
Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 2013; 269: 927-37. 10.1148/radiol.13130387TakumaYTakabatakeHMorimotoYToshikuniNKayaharaTMakinoYComparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteriaRadiology20132699273710.1148/radiol.13130387Open DOISearch in Google Scholar
Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010; 195: 758-65. 10.2214/AJR.09.2954KimYSLeeWJRhimHLimHKChoiDLeeJYThe minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusionAJR Am J Roentgenol20101957586510.2214/AJR.09.2954Open DOISearch in Google Scholar
Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, et al. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Oncol Rep 2010; 23: 493-7.HiraokaAHirookaMKoizumiYHidakaSUeharaTIchikawaSModified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume systemOncol Rep2010234937Search in Google Scholar
Numata K, Fukuda H, Morimoto M, Kondo M, Nozaki A, Oshima T, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol 2012; 81: 2746-53. 10.1016/j.ejrad.2011.11.052NumataKFukudaHMorimotoMKondoMNozakiAOshimaTUse of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinomaEur J Radiol20128127465310.1016/j.ejrad.2011.11.052Open DOISearch in Google Scholar
Minami Y, Minami T, Chishina H, Kono M, Arizumi T, Takita M, et al. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases. Dig Dis 2016; 34: 687-91. 10.1159/000448857MinamiYMinamiTChishinaHKonoMArizumiTTakitaMUS-US Fusion Imaging in Radiofrequency Ablation for Liver MetastasesDig Dis2016346879110.1159/000448857Open DOISearch in Google Scholar